Grifols is a leading global producer of plasma-derived protein therapies for patients who have rare, genetic diseases and potentially life-threatening infections. Grifols’ diagnostic systems are composed of analyzers, instrumentation and reagents that satisfy the demands of clinical laboratory professionals who require precise results and a reliable diagnosis. Grifols can also offer high-quality contract manufacturing services.
Grifols Nordic
Produces life-saving protein therapies for patients and provides hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care.
